Mark S. Fineman
No más puestos en curso
Historial de carrera de Mark S. Fineman
Antiguos cargos conocidos de Mark S. Fineman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Psylin Neurosciences, Inc.
 Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Psylin Neurosciences, Inc. discovers and develops peptide hormones for the treatment of psychiatric disorders. The firm is formed in partnership between Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. The company was founded on January 30, 2007 and is located in San Diego, CA | Director Técnico/Científico/I+D | - | - |
| Consejero General | - | - | |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/01/2013 | - |
Formación de Mark S. Fineman.
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
| Vrije Universiteit Amsterdam | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Países Bajos | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| General Counsel | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Elcelyx Therapeutics, Inc.
Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Psylin Neurosciences, Inc.
Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Psylin Neurosciences, Inc. discovers and develops peptide hormones for the treatment of psychiatric disorders. The firm is formed in partnership between Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. The company was founded on January 30, 2007 and is located in San Diego, CA | Health Technology |
- Bolsa de valores
- Insiders
- Mark S. Fineman
- Experiencia
